参考文献/References:
[1] TRAN A P,SILVER J.Neuroscience.Systemically treating spinal cord injury[J].Science,2015,348(6232):285-286.
[2] NOONAN V K,FINGAS M,FARRY A,et al.Incidence and prevalence of spinal cord injury in Canada:a national perspective[J].Neuroepidemiology,2012,38(4):219-226.
[3] CHEN Y,HE Y,DEVIVO M J.Changing demographics and injury profile of new traumatic spinal cord injuries in the United States,1972-2014[J].Arch Phys Med Rehabil,2016,97(10):1610-1619.
[4] FURLAN A D,PENNICK V,BOMBARDIER C,et al.2009 updated method guidelines for systematic reviews in the cochrane back review group[J].Spine(Phila Pa 1976),2009,34(18):1929-1941.
[5] HURLBERT R J.Methylprednisolone for the treatment of acute spinal cord injury:point[J].Neurosurgery,2014,61(Suppl 1):32-35.
[6] 国际神经修复学会暨中国神经修复学会.脊髓损伤神经修复临床治疗指南(IANR/CANR2019年版)[J].西部医学,2020,32(6):790-802.
[7] SINESCU C,POPA F,GRIGOREAN V T,et al.Molecular basis of vascular events following spinal cord injury[J].J Med Life,2010,3(3):254-261.
[8] SCHWARTZ G,FEHLINGS M G.Secondary injury mechanisms of spinal cord trauma:a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole[J].Prog Brain Res,2002,137:177-190.
[9] MARTI?N S,IBARRA A.Pharmacological neuroprotective therapy for acute spinal cord injury:state of the art[J].Mini Rev Med Chem,2008,8(3):222-230.
[10] MACAYA D J,HAYAKAWA K,ARAI K,et al.Astrocyte infiltration into injectable collagen-based hydrogels containing FGF-2 to treat spinal cord injury[J].Biomaterials,2013,34(14):3591-3602.
[11] SCHWAB M E.Repairing the injured spinal cord[J].Science,2002,295(5557):1029-1031.
[12] LU P.Stem cell transplantation for spinal cord injury re-pair[J].Prog Brain Res,2017,231:1-32.
[13] HAO Y,COLLINS C.Intrinsic mechanisms for axon regeneration:insights from injured axons in Drosophila[J].Curr Opin Genet Dev,2017,44:84-91.
[14] SAKAMOTO K,KADOMATSU K.Mechanisms of axon regeneration:the significance of proteoglycans[J].BiochimBiophys Acta Gen Subj,2017,1861(10):2435-2441.
[15] MOTHE A J,TATOR C H.Review of transplantation of neural stem/progenitor cells for spinal cord injury[J].Int J Dev Neurosci,2013,31(7):701-713.
[16] ZHU Y,UEZONO N,YASUI T,et al.Neural stem cell therapy aiming at better functional recovery after spinal cord injury[J].Dev Dyn,2018,247(1):75-84.
[17] OKANO H,YAMANAKA S.IPS cell technologies:significance and applications to CNS regeneration and disease[J].Mol Brain,2014,7:22.
[18] TAKAHASHI K,YAMANAKA S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].Cell,2006,126(4):663-676.
[19] TSUJI O,MIURA K,OKADA Y,et al.Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury[J].Proc Nati Acad Sci USA,2010,107(28):12704-12709.
[20] NORI S,OKADA Y,YASUDA A,et al.Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice[J].Proc Nati Acad Sci USA,2011,108(40):16825-16830.
[21] KOBAYASHI Y,OKADA Y,ITAKURA G,et al.Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity[J].PloS one,2012,7(12):e52787.
[22] FUJIMOTO Y,ABEMATSU M,FALK A,et al.Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells[J].Stem Cells,2012,30(6):1163-1173.
[23] NUTT S E,CHANG E A,SUHR S T,et al.Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model[J].Exp Neurol,2013,248:491-503.
[24] LU P,WOODRUFF G,WANG Y,et al.Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury[J].Neuron,2014,83(4):789-796.
[25] RUZICKA J,ROMANYUK N,JIRAKOVA K,et al.The effect of ips-derived neural progenitors seeded on laminin-coated phema-moetacl hydrogel with dual porosity in a rat model of chronic spinal cord injury[J].Cell Transplant,2019,28(4):400-412.
[26] OKUBO T,NAGOSHI N,KOHYAMA J,et al.Treatment with a gamma-secretase inhibitor promotes functional recovery in human ipsc- derived transplants for chronic spinal cord injury[J].Stem Cell Reports,2018,11(6):1416-1432.
[27] NORI S,KHAZAEI M,AHUJA C S,et al.Humanoligodendrogenic neural progenitor cells delivered with chondroitinase ABC facilitate functional repair of chronic spinal cord injury[J].Stem Cell Reports,2018,11(6):1433-1448.
[28] YOUSEFIFARD M,RAHIMI-MOVAGHAR V,NASIRINEZHAD F,et al.Neural stem/progenitor cell transplantation for spinal cord injury treatment; a systematic review and meta-analysis[J].Neuroscience,2016,322:377-397.
[29] QIN C,GUO Y,YANG D G,et al.Induced pluripotent stem cell transplantation improves locomotor recovery in rat models of spinal cord injury:a systematic review and meta-analysis of randomized controlled trials[J].Cell Physiol Biochem,2018,47(5):1835-1852.
[30] OH J,LEE K I,KIM H T,et al.Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury[J].Stem Cell Res Ther,2015,6(1):125.
[31] POMESHCHIK Y,PUTTONEN K A,KIDIN I,et al.Transplanted human induced pluripotent stem cell-derived neural progenitor cells do not promote functional recovery of pharmacologically immunosuppressed mice with spinal cord injury[J].Cell Transplant,2015,24(9):1799-1812.
[32] ROMANYUK N,AMEMORI T,TURNOVCOVA K,et al.Beneficial effect of human induced pluripotent stem cell-derived neural precursors in spinal cord injury repair[J].Cell Transplant,2015,24(9):1799-1812.
[33] NORI S,OKADA Y,NISHIMURA S,et al.Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model:oncogenic transformation with epithelial-mesenchymal transition[J].Stem Cell Reports,2015,4(3):360-373.
[34] IIDA T,IWANAMI A,SANOSAKA T,et al.Whole-genome dna methylation analyses revealed epigenetic instability in tumorigenic human iPS cell-derived neural stem/progenitor cells[J].Stem Cells,2017,35(5):1316-1327.
[35] OKUBO T,IWANAMI A,KOHYAMA J,et al.Pretreatment with a gamma-secretase inhibitor prevents tumor-like overgrowth in human iPSC-derived transplants for spinal cord injury[J].Stem Cell Reports,2016,7(4):649-663.
[36] PARR C J,KATAYAMA S,MIKI K,et al.MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells[J].Sci Rep,2016,6:32.
[37] SIMPSON-ABELSON M R,LOYALL J L,LEHMAN H K,et al.Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-кB and NFAT signaling in tumor-associated T cells[J].Cancer Immun,2013,13:14.
[38] MIURA K,OKADA Y,AOI T,et al.Variation in the safety of induced pluripotent stem cell lines[J].Nat Biotechnol,2009,27(8):743-745.
[39] GOLDRING C E,DUFFY P A,BENVENISTY N,et al.Assessing the safety of stem cell therapeutics[J].Cell Stem Cell,2011,8(6):618-628.
[40] BEN-DAVID U,BENVENISTY N.The tumorigenicity of human embryonic and induced pluripotent stem cells[J].Nat Rev Cancer,2011,11(4):268-277.
[41] MARION R M,STRATI K,LI H,et al.A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity[J].Nature,2009,460(7259):1149-1153.
[42] UTIKAL J,POLO J M,STADTFELD M,et al.Immortalization eliminates a roadblock during cellular reprogramming into iPScells[J].Nature,2009,460(7259):1145-1148.
[43] HONG H,TAKAHASHI K,ICHISAKA T,et al.Suppression of induced pluripotent stem cell generation by the p53-p21 pathway[J].Nature,2009,460(7259):1132-1135.
[44] KAWAMURA T,SUZUKI J,WANG Y V,et al.Linking the p53 tumour suppressor pathway to somatic cell reprogramming[J].Nature,2009,460(7259):1140-1144.
[45] LIU Y,ZHENG Y,LI S,et al.Human neural progenitors derived from integration-free iPSCs for SCI therapy[J].Stem Cell Res,2017,19:55-64.
[46] SCHOENHALS M,KASSAMBARA A,DE VOS J,et al.Embryonic stem cell markers expression in cancers[J].Biochem Biophys Res Commun,2009,383(2):157-162.
[47] MAYSHAR Y,BEN-DAVID U,LAVON N,et al.Identification and classification of chromosomal aberrations in human induced pluripotent stem cells[J].Cell Stem Cell, 2010,7(4):521-531.
[48] LIU Z,TANG Y,Lü S,et al.Thetumourigenicity of iPS cells and their differentiated derivates[J].J Cell Mol Med,2013,17(6):782-791.
相似文献/References:
[1]全仁夫,胡华辉,黄小龙,等.电针秩边穴和水道穴对急性脊髓不完全损伤大鼠脑皮质代谢物的影响[J].中医正骨,2016,28(11):1.
QUAN Renfu,HU Huahui,HUANG Xiaolong,et al.Effect of electroacupuncture at Point BL54(Zhibian)and Point ST28(Shuidao)on cerebral cortex metabolites in rats with acute incomplete spinal cord injuries[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):1.
[2]谭明生,齐英娜,姜良海,等.球囊导管构建大鼠督脉瘀阻型上颈脊髓损伤模型的研究[J].中医正骨,2016,28(12):1.
TAN Mingsheng,QI Yingna,JIANG Lianghai,et al.A governor-vessel-blockade-type upper cervical spinal cord injury rat model created using Foley’s tube[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):1.
[3]杜伟斌,陈荣良,俆亦生,等.电针夹脊穴和督脉穴对急性脊髓损伤家兔后肢神经功能的影响及其作用机制[J].中医正骨,2016,28(12):13.
DU Weibin,CHEN Rongliang,XU Yisheng,et al.Effects of electroacupuncture at Point JIAJI(EX-B2)and Point governor vessel on neural function of hindlimbs in rabbits with acute spinal cord injury and the mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):13.
[4]齐英娜,王威,吴鑫杰,等.脊髓损伤后微循环的变化及微循环障碍的药物治疗进展[J].中医正骨,2017,29(10):47.
[5]齐英娜,王延雷,吴鑫杰,等.改进球囊导管法构建大鼠急性压迫型上颈脊髓损伤模型及模型大鼠伤后早期血液流变学指标观察[J].中医正骨,2017,29(11):26.
QI Yingna,WANG Yanlei,WU Xinjie,et al.Experimental research on acute-compression-type upper cervical spinal cord injury rat models created by using improved Foley's tube method and early observation on post-traumatic hemorheological indexes in rat models[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):26.
[6]赵守军,熊文化,许柯.细胞因子基因转染的骨骺干细胞复合明胶-硫酸软骨素-透明质酸钠支架修复大鼠骨骺生长板缺损的实验研究[J].中医正骨,2018,30(02):10.
ZHAO Shoujun,XIONG Wenhua,XU Ke.A combination of epiphysis stem cell transfected with cytokine genes and bio-scaffold consists of gelatin,chondroitin sulfate and sodium hyaluronate for repairing epiphyseal growth plate defect in rats:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(02):10.
[7]吴鑫杰,谭明生,移平.NOD样受体蛋白3炎性小体在创伤性脊髓损伤中的作用[J].中医正骨,2019,31(02):31.
[8]张维新,童培建.干细胞移植治疗股骨头坏死的研究进展[J].中医正骨,2019,31(05):28.
[9]王姣姣,周峻,王延雷,等.“椎管减压,疏通督脉”论治脊髓损伤的学术思想探析[J].中医正骨,2020,32(10):67.
[10]李玮农,赵继荣,邓强,等.慢性脊髓损伤动物模型的研究进展[J].中医正骨,2021,33(03):40.
LI Weinong,ZHAO Jirong,DENG Qiang,et al.Advancement of research on animal models of chronic spinal cord injury[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(02):40.